[
    [
        {
            "time": "",
            "original_text": "欧普康视：将加强对非自营的（由合作伙伴运营的）视光终端的培训和管理",
            "features": {
                "keywords": [
                    "欧普康视",
                    "非自营",
                    "视光终端",
                    "培训",
                    "管理"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "欧普康视：将加强对非自营的（由合作伙伴运营的）视光终端的培训和管理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "调研记录|欧普康视（300595.SZ）：计划通过三年建立1300家视光中心",
            "features": {
                "keywords": [
                    "欧普康视",
                    "视光中心",
                    "三年计划",
                    "扩张"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "调研记录|欧普康视（300595.SZ）：计划通过三年建立1300家视光中心",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "欧普康视：角膜塑形镜现在属于自费产品，价格由市场调节",
            "features": {
                "keywords": [
                    "欧普康视",
                    "角膜塑形镜",
                    "自费产品",
                    "市场价格"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "欧普康视：角膜塑形镜现在属于自费产品，价格由市场调节",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "2021年医药生物中期策略报告：需求长期景气 布局创新、医疗服务和消费主线",
            "features": {
                "keywords": [
                    "医药生物",
                    "中期策略",
                    "需求景气",
                    "创新",
                    "医疗服务",
                    "消费"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "2021年医药生物中期策略报告：需求长期景气 布局创新、医疗服务和消费主线",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "基金最新调研这些上市公司 ，欧普康视、南玻集团最关注！",
            "features": {
                "keywords": [
                    "基金",
                    "调研",
                    "欧普康视",
                    "南玻集团"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "制造业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "基金最新调研这些上市公司 ，欧普康视、南玻集团最关注！",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]